{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:06:32Z","timestamp":1751367992118},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.leukres.2009.06.015","type":"journal-article","created":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T08:23:45Z","timestamp":1247300625000},"page":"38-45","source":"Crossref","is-referenced-by-count":7,"title":["Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients"],"prefix":"10.1016","volume":"34","author":[{"given":"Barbara","family":"Zdzisi\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wejksza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Walter-Croneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar A.","family":"Turski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyna","family":"Kandefer-Szersze\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.06.015_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev"},{"key":"10.1016\/j.leukres.2009.06.015_bib2","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990","article-title":"Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors","volume":"10","author":"Swartz","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.leukres.2009.06.015_bib3","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits \u03b17 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"issue":"16","key":"10.1016\/j.leukres.2009.06.015_bib4","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1002\/jnr.21446","article-title":"N-Methyl-d-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus","volume":"85","author":"Luccini","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.leukres.2009.06.015_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","article-title":"Kynurenic acid has a dual action on AMPA receptor responses","volume":"402","author":"Prescott","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.leukres.2009.06.015_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.leukres.2009.06.015_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1520-6769(199905\/06)24:3<173::AID-NRC6>3.0.CO;2-S","article-title":"Intrapartum levels of endogenous glutamate antagonist-kynurenic acid in amniotic fluid, umbilical and maternal blood","volume":"24","author":"Milart","year":"1999","journal-title":"Neurosci Res Commmun"},{"key":"10.1016\/j.leukres.2009.06.015_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0003-2697(90)90309-W","article-title":"Measurements of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection","volume":"185","author":"Swartz","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.leukres.2009.06.015_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0042-6989(02)00682-X","article-title":"Alterations of kynurenic acid content in retina in response to retinal ganglion cell damage","volume":"43","author":"Rejdak","year":"2003","journal-title":"Vision Res"},{"key":"10.1016\/j.leukres.2009.06.015_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00296-005-0057-4","article-title":"Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro","volume":"26","author":"Parada-Turska","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.leukres.2009.06.015_bib11","first-page":"393","article-title":"Kynurenic acid in human saliva\u2013does it influence oral microflora?","volume":"58","author":"Kuc","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.leukres.2009.06.015_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00726-007-0631-z","article-title":"Micromolar concentration of kynurenic acid in rat small intestine","volume":"35","author":"Kuc","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.leukres.2009.06.015_bib13","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2009.06.015_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurement in Huntington's disease striatum: evidence for reduced formation of kynurenic acid","volume":"55","author":"Beal","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.leukres.2009.06.015_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1600-0404.2003.00076.x","article-title":"Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis","volume":"107","author":"Ilzecka","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.leukres.2009.06.015_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.leukres.2009.06.015_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.leukres.2009.06.015_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and \u03b22-microglobulin in cerebrospinal fluid and serum of HIV-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.leukres.2009.06.015_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.leukres.2008.05.023","article-title":"Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia\/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity","volume":"33","author":"Hoshi","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.06.015_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4161\/cbt.6.8.4446","article-title":"Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer","volume":"6","author":"Karanikas","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.leukres.2009.06.015_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.canlet.2004.10.033","article-title":"Tryptophan degradation in patients with gynecological cancer correlates with immune activation","volume":"223","author":"Schroecksnadel","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2009.06.015_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2009.06.015_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect of tumor-infiltrating T cells","volume":"15","author":"Brandacher","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2009.06.015_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2009.06.015_bib25","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1016\/S0021-9258(18)82284-0","article-title":"A mechanism for increased quinolinic acid formation following acute systemic immune stimulation","volume":"268","author":"Saito","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2009.06.015_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.leukres.2009.06.015_bib27","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood-2002-11-3368","article-title":"Beta2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells","volume":"15","author":"Xie","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.015_bib28","first-page":"161","article-title":"Red Espanola de Mieloma Multiple. Interactions between clonal plasma cells and the immune system in plasma cell dyscrasias","volume":"18","author":"Perez-Andres","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.leukres.2009.06.015_bib29","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1182\/blood-2006-11-056242","article-title":"Expansion of immunoglobulin autoreactive T-helper cells in multiple myeloma","volume":"111","author":"Ostad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.015_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.06.015_bib31","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staining system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.06.015_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","article-title":"Decreased serum and red blood cell kynurenic acid levels in Alzheimer\u2018s disease","volume":"50","author":"Hartai","year":"2007","journal-title":"Neurochemistry Int"},{"key":"10.1016\/j.leukres.2009.06.015_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000086295","article-title":"Age-related increase of kynurenic acid in human cerebrospinal fluid\u2014IgG and \u03b22-microglobulin changes","volume":"14","author":"Kepplinger","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.leukres.2009.06.015_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2006.09.019","article-title":"Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino-acids","volume":"377","author":"Fukushima","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.leukres.2009.06.015_bib35","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogenic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.015_bib36","first-page":"214","article-title":"Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies","volume":"73","author":"Massaia","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.leukres.2009.06.015_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<217::AID-AJH15>3.0.CO;2-C","article-title":"Risk of monoclonal gammopathy of undetermined significance: a case-referent study","volume":"53","author":"Pasqualetti","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2009.06.015_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-008-0513-6","article-title":"IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan metabolism","volume":"58","author":"Lob","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2009.06.015_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jamcollsurg.2007.12.014","article-title":"Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection","volume":"206","author":"Witkiewicz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.leukres.2009.06.015_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00210961","article-title":"Weight loss in patients with hematological neoplasia is associated with immune stimulation","volume":"71","author":"Denz","year":"1993","journal-title":"Clin Invest"},{"key":"10.1016\/j.leukres.2009.06.015_bib41","first-page":"699","article-title":"Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraperesis, and adult T-cell leukaemia\/lymphoma","volume":"5","author":"Giusti","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.leukres.2009.06.015_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1593\/neo.04658","article-title":"Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer","volume":"7","author":"Astigiano","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2009.06.015_bib43","first-page":"826","article-title":"The immune effects of TRYCATs (tryptophan catabolites along IDO pathway): relevance for depression \u2013 and other conditions characterized by tryptophan depletion induced by inflammation","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.leukres.2009.06.015_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.leukres.2009.06.015_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000049069","article-title":"Tryptophan metabolism via kynurenine pathway in experimental chronic renal failure","volume":"90","author":"Pawlak","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.leukres.2009.06.015_bib46","first-page":"755","article-title":"Kynurenine and its metabolites in the rat with experimental renal insufficiency","volume":"52","author":"Pawlak","year":"2001","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.leukres.2009.06.015_bib47","first-page":"91","article-title":"Maintenance hemodialysis in myeloma kidney disease","volume":"126","author":"Vaziri","year":"1977","journal-title":"Western J Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T12:19:58Z","timestamp":1633695598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609002926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0145212609002926"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.06.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}